Immune Pharmaceuticals Announces New Data with Topical Cyclosporine...
SWI Editorial Staff2016-02-01T08:47:59-08:00Immune Acquires Worldwide Rights and Accelerates Development for the Treatment of Psoriasis and Atopic Dermatitis NEW YORK, Jan. 4, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage ...